In this interview, Dr. Michelle Fraser highlights how base editing and AI-designed enzymes are expanding therapeutic ...

Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.

US Food and Drug Administration (FDA) officials credited recent advancements in regulatory science and flexibilities with ...

The biotech aims to quickly bring three gene therapies to market, and overcome the development and commercialization challenges that have dogged the space.

The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen receptor T-cell therapies in autoimmune and rheumatic diseases.“It is quite ...

In heart failure, the heart can no longer supply the body with enough blood. The condition often develops over many years, ...

Delaware is the best place for life science innovation and investment to thrive. Our homegrown life science firms need sustained investment.

Combination therapy is essentially a one-two punch at cancer—sometimes with multiple punches. For people with lung cancer, it ...

LumaCyte today announced that its analytical approach has been included in the newly published International Organization for Standardization (ISO) global standard for gene delivery systems, ISO 16921 ...

A treatment used a gene-editing tool to turn off a gene that prevents LDL cholesterol and triglycerides from being cleared ...

A quiet signal inside a tumor may soon guide how surgeons treat early lung cancer. Researchers now report that hidden genetic ...